Skip to content

XOMA Corporation XOMA Free cash flow

Discontinued — last reported Q4 '24

Free cash flow at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$48.46M+289%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$34.79M-28.4%
Zymeworks logo
ZymeworksZYME
-$45.93M-1,242%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$198M-18.6%
ALN
Alnylam PharmaceuticalsALNY
$48.67M+138%
Xencor logo
XencorXNCR
-$68.24M-286%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%

Valuation

See full
Market cap$745.16M+159%
Enterprise value$784.29M+151%
P/E22×
P/S15.4×+8.6×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Calculated from XOMA Corporation’s reported figures.

The official record: XOMA Corporation’s 10-K, filed March 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's free cash flow?
XOMA Corporation (XOMA) reported free cash flow of -$2.91M in Q4 2024.
How has XOMA Corporation's free cash flow changed year-over-year?
XOMA Corporation's free cash flow increased by 36.0% year-over-year, from -$4.54M to -$2.91M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.